{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:29:54Z","timestamp":1783024194778,"version":"3.54.6"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      This exploratory study investigated alterations in cerebral metabolism and metabolic connectivity using\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography (F-18 FDG-PET) in patients with multiple myeloma with neurotoxicity after B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>The retrospective study included 20 BCMA CAR T-cell therapy recipients who underwent brain F-18 FDG-PET imaging (15 with baseline PET scans). Brain metabolism was quantified using standardized uptake value ratios (SUVRs), with the cerebellum as the reference region. Metabolic connectivity was assessed using correlation matrices and network topology metrics. Metabolic patterns were age-adjusted and compared between patients with and without neurotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Neurotoxicity occurred in 7 patients. SUVR analysis involving those with neurotoxicity demonstrated significantly reduced post-treatment FDG uptake in the left precentral gyrus and striatum. Greater declines were observed in FDG uptake within the left inferior occipital cortex and striatum in patients with neurotoxicity than in those without. Metabolic connectivity analysis identified 508 significantly altered regional pairs, primarily with reduced frontotemporal correlations. Hub node analysis demonstrated a redistribution of network centrality from higher-order cortical regions to temporal and occipital areas, with reduced centrality in the insular and limbic regions among patients with neurotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Patients with neurotoxicity after BCMA CAR T-cell therapy demonstrated distinct metabolic-level and network-level differences on F-18 FDG-PET, highlighting the potential of brain PET imaging to elucidate the underlying mechanisms and warranting further investigation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006496","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:02:43Z","timestamp":1777903363000},"page":"e545-e553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Neurotoxicity-Associated Brain FDG-PET Alterations Following BCMA CAR T-Cell Therapy in Multiple Myeloma"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-9621","authenticated-orcid":false,"given":"Kuan-Yin","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, National Taiwan University Cancer Center and College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Zhmakin","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Shiun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tri-service General Hospital and School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Kai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3389\/fimmu.2018.01821","article-title":"Targeting B cell maturation antigen (BCMA) in multiple myeloma: potential uses of BCMA-based immunotherapy","volume":"9","author":"Cho","year":"2018","journal-title":"Front Immunol"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N Engl J Med"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/brain\/awz053","article-title":"Neurological toxicities associated with chimeric antigen receptor T-cell therapy","volume":"142","author":"Rubin","year":"2019","journal-title":"Brain"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11940-019-0580-3","article-title":"Chimeric antigen receptor T cell-related neurotoxicity: mechanisms, clinical presentation, and approach to treatment","volume":"21","author":"Rice","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaneurol.2020.2703","article-title":"Clinical predictors of neurotoxicity after chimeric antigen receptor T-cell therapy","volume":"77","author":"Rubin","year":"2020","journal-title":"JAMA Neurol"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-021-01564-7","article-title":"Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy","volume":"27","author":"Van Oekelen","year":"2021","journal-title":"Nat Med"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-022-00629-1","article-title":"Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies","volume":"12","author":"Cohen","year":"2022","journal-title":"Blood Cancer J"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00415-020-10237-3","article-title":"Neurological updates: neurological complications of CAR-T therapy","volume":"268","author":"Tallantyre","year":"2021","journal-title":"J Neurol"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"15353508241257924","DOI":"10.1177\/15353508241257924","article-title":"PET\/CT in the evaluation of CAR-T cell immunotherapy in hematological malignancies","volume":"23","author":"Singh","year":"2024","journal-title":"Mol Imaging"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/tomography10060066","article-title":"The role of [(18)F]FDG PET\/CT in predicting toxicity in patients with NHL treated with CAR-T: a systematic review","volume":"10","author":"Quartuccio","year":"2024","journal-title":"Tomography"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1212\/NXI.0000000000001136","article-title":"Cortical and subcortical dysmetabolism are dynamic markers of clinical disability and course in anti-LGI1 encephalitis","volume":"9","author":"Rissanen","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R15-20260702","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrneurol.2017.144","article-title":"Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives","volume":"13","author":"Yshii","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"R16-20260702","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jnci\/djz168","article-title":"Potential effect of immunotherapy agents on cognitive function in cancer patients","volume":"112","author":"Joly","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"R17-20260702","doi-asserted-by":"crossref","first-page":"e0178798","DOI":"10.1371\/journal.pone.0178798","article-title":"BRAPH: a graph theory software for the analysis of brain connectivity","volume":"12","author":"Mijalkov","year":"2017","journal-title":"PLOS One"},{"key":"R18-20260702","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"key":"R19-20260702","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neubiorev.2017.03.018","article-title":"Small-world human brain networks: perspectives and challenges","volume":"77","author":"Liao","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"R20-20260702","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev-psych-122414-033634","article-title":"Modular brain networks","volume":"67","author":"Sporns","year":"2016","journal-title":"Annu Rev Psychol"},{"key":"R21-20260702","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.tics.2013.09.012","article-title":"Network hubs in the human brain","volume":"17","author":"van den Heuvel","year":"2013","journal-title":"Trends Cogn Sci"},{"key":"R22-20260702","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MNM.0000000000001951","article-title":"Network topology and metabolic alterations in early- and mid-stage Parkinson\u2019s disease: insights from fluorodeoxyglucose PET imaging","volume":"46","author":"Li","year":"2025","journal-title":"Nucl Med Commun"},{"key":"R23-20260702","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R24-20260702","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mrm.1910340409","article-title":"Functional connectivity in the motor cortex of resting human brain using echo-planar MRI","volume":"34","author":"Biswal","year":"1995","journal-title":"Magn Reson Med"},{"key":"R25-20260702","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/jcbfm.1984.73","article-title":"Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input","volume":"4","author":"Horwitz","year":"1984","journal-title":"J Cereb Blood Flow Metab"},{"key":"R26-20260702","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00259-008-0808-z","article-title":"Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults","volume":"35","author":"Lee","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-20260702","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/brain.2012.0086","article-title":"Metabolic brain covariant networks as revealed by FDG-PET with reference to resting-state fMRI networks","volume":"2","author":"Di","year":"2012","journal-title":"Brain Connect"},{"key":"R28-20260702","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/WCO.0000000000000494","article-title":"Metabolic connectivity: methods and applications","volume":"30","author":"Yakushev","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"R29-20260702","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/cercor\/bhaa393","article-title":"Metabolic and hemodynamic resting-state connectivity of the human brain: a high-temporal resolution simultaneous BOLD-fMRI and FDG-fPET multimodality study","volume":"31","author":"Jamadar","year":"2021","journal-title":"Cereb Cortex"},{"key":"R30-20260702","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.neurobiolaging.2012.01.005","article-title":"Resting metabolic connectivity in prodromal Alzheimer\u2019s disease. A European Alzheimer Disease Consortium (EADC) project","volume":"33","author":"Morbelli","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R31-20260702","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/0271678X16654497","article-title":"Metabolic connectomics targeting brain pathology in dementia with Lewy bodies","volume":"37","author":"Caminiti","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"R32-20260702","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1038\/s41598-017-04102-z","article-title":"Altered brain metabolic connectivity at multiscale level in early Parkinson\u2019s disease","volume":"7","author":"Sala","year":"2017","journal-title":"Sci Rep"},{"key":"R33-20260702","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0271678X15622465","article-title":"Metabolic connectivity for differential diagnosis of dementing disorders","volume":"37","author":"Titov","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"R34-20260702","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jtct.2022.03.006","article-title":"Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review","volume":"28","author":"Grant","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"R35-20260702","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jon.13135","article-title":"Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma","volume":"33","author":"Morbelli","year":"2023","journal-title":"J Neuroimaging"},{"key":"R36-20260702","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jamaneurol.2024.2506","article-title":"Parkinsonism following chimeric antigen receptor T cell therapy","volume":"81","author":"Gudera","year":"2024","journal-title":"JAMA Neurol"},{"key":"R37-20260702","doi-asserted-by":"crossref","first-page":"1444010","DOI":"10.3389\/fimmu.2024.1444010","article-title":"Case report: treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen","volume":"15","author":"Aliakbar","year":"2024","journal-title":"Front Immunol"},{"key":"R38-20260702","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41824-024-00232-6","article-title":"FDG-PET-based brain network analysis: a brief review of metabolic connectivity","volume":"9","author":"Tuan","year":"2025","journal-title":"EJNMMI Rep"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:10:11Z","timestamp":1783023011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006496","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}